John P. McLaughlin
2014
In 2014, John P. McLaughlin earned a total compensation of $4.1M as President and Chief Executive Officer at PDL BioPharma, a 41% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,359,424 |
|---|---|
| Salary | $716,108 |
| Stock Awards | $984,510 |
| Other | $10,000 |
| Total | $4,070,042 |
McLaughlin received $2.4M in non-equity incentive plan, accounting for 58% of the total pay in 2014.
McLaughlin also received $716.1K in salary, $984.5K in stock awards and $10K in other compensation.
Rankings
In 2014, John P. McLaughlin's compensation ranked 2,078th out of 13,032 executives tracked by ExecPay. In other words, McLaughlin earned more than 84.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,078 out of 13,032 | 84th |
Division Manufacturing | 733 out of 4,966 | 85th |
Major group Chemicals And Allied Products | 229 out of 1,686 | 86th |
Industry group Drugs | 176 out of 1,365 | 87th |
Industry Biological Products, Except Diagnostic Substances | 26 out of 236 | 89th |
Source: SEC filing on April 28, 2017.
McLaughlin's colleagues
We found four more compensation records of executives who worked with John P. McLaughlin at PDL BioPharma in 2014.